

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle exocytosis (GO:0016079) | 5.62259247 |
| 2 | vocalization behavior (GO:0071625) | 5.61756218 |
| 3 | neuron cell-cell adhesion (GO:0007158) | 5.58842018 |
| 4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.38860918 |
| 5 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.35259891 |
| 6 | protein localization to synapse (GO:0035418) | 5.12978492 |
| 7 | glutamate secretion (GO:0014047) | 5.00737197 |
| 8 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.87756720 |
| 9 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.87607317 |
| 10 | establishment of mitochondrion localization (GO:0051654) | 4.80697834 |
| 11 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.80346920 |
| 12 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.77998608 |
| 13 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.67307559 |
| 14 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.50873943 |
| 15 | synaptic vesicle maturation (GO:0016188) | 4.50013508 |
| 16 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.47631283 |
| 17 | presynaptic membrane assembly (GO:0097105) | 4.44141804 |
| 18 | postsynaptic membrane organization (GO:0001941) | 4.40499774 |
| 19 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.39827386 |
| 20 | locomotory exploration behavior (GO:0035641) | 4.30226049 |
| 21 | neurotransmitter secretion (GO:0007269) | 4.29455996 |
| 22 | regulation of synaptic vesicle transport (GO:1902803) | 4.26800496 |
| 23 | neuron recognition (GO:0008038) | 4.22217222 |
| 24 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.21205714 |
| 25 | presynaptic membrane organization (GO:0097090) | 4.17758547 |
| 26 | exploration behavior (GO:0035640) | 4.07352310 |
| 27 | neuron-neuron synaptic transmission (GO:0007270) | 4.03663992 |
| 28 | sequestering of actin monomers (GO:0042989) | 4.01583991 |
| 29 | synaptic transmission, glutamatergic (GO:0035249) | 3.97204450 |
| 30 | neuronal action potential propagation (GO:0019227) | 3.92063791 |
| 31 | glutamate receptor signaling pathway (GO:0007215) | 3.91169537 |
| 32 | layer formation in cerebral cortex (GO:0021819) | 3.90230140 |
| 33 | positive regulation of synapse maturation (GO:0090129) | 3.89202744 |
| 34 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.87772175 |
| 35 | regulation of synapse structural plasticity (GO:0051823) | 3.87222696 |
| 36 | cell migration in hindbrain (GO:0021535) | 3.74862724 |
| 37 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.74286203 |
| 38 | axonal fasciculation (GO:0007413) | 3.73114624 |
| 39 | proline transport (GO:0015824) | 3.70627890 |
| 40 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.70540809 |
| 41 | nucleobase catabolic process (GO:0046113) | 3.69124939 |
| 42 | negative regulation of microtubule polymerization (GO:0031115) | 3.69109498 |
| 43 | positive regulation of mitochondrial fission (GO:0090141) | 3.68790266 |
| 44 | glycosphingolipid biosynthetic process (GO:0006688) | 3.59967381 |
| 45 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.58904154 |
| 46 | behavioral response to nicotine (GO:0035095) | 3.57828286 |
| 47 | positive regulation of synapse assembly (GO:0051965) | 3.56119799 |
| 48 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.53912293 |
| 49 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.49591345 |
| 50 | protein localization to cilium (GO:0061512) | 3.49041425 |
| 51 | neural tube formation (GO:0001841) | 3.48460821 |
| 52 | neurotransmitter transport (GO:0006836) | 3.44637847 |
| 53 | gamma-aminobutyric acid transport (GO:0015812) | 3.44345497 |
| 54 | dendritic spine morphogenesis (GO:0060997) | 3.42530723 |
| 55 | sympathetic nervous system development (GO:0048485) | 3.42324940 |
| 56 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.41358693 |
| 57 | synaptic vesicle endocytosis (GO:0048488) | 3.39944771 |
| 58 | regulation of postsynaptic membrane potential (GO:0060078) | 3.39787869 |
| 59 | hippocampus development (GO:0021766) | 3.38961516 |
| 60 | regulation of feeding behavior (GO:0060259) | 3.38069282 |
| 61 | long-term synaptic potentiation (GO:0060291) | 3.36603478 |
| 62 | positive regulation of membrane potential (GO:0045838) | 3.36404674 |
| 63 | startle response (GO:0001964) | 3.34245677 |
| 64 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.34123135 |
| 65 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.34123135 |
| 66 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.33685171 |
| 67 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 3.33601007 |
| 68 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.32282975 |
| 69 | retinal ganglion cell axon guidance (GO:0031290) | 3.31050848 |
| 70 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.30846243 |
| 71 | synapse assembly (GO:0007416) | 3.29155017 |
| 72 | regulation of neurotransmitter secretion (GO:0046928) | 3.28803553 |
| 73 | mitochondrion transport along microtubule (GO:0047497) | 3.28494266 |
| 74 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.28494266 |
| 75 | neurofilament cytoskeleton organization (GO:0060052) | 3.27068830 |
| 76 | response to histamine (GO:0034776) | 3.27013963 |
| 77 | cerebellar granule cell differentiation (GO:0021707) | 3.26858741 |
| 78 | limb bud formation (GO:0060174) | 3.22041904 |
| 79 | transferrin transport (GO:0033572) | 3.21853478 |
| 80 | regulation of synapse maturation (GO:0090128) | 3.20427685 |
| 81 | auditory behavior (GO:0031223) | 3.18765723 |
| 82 | regulation of neurotransmitter levels (GO:0001505) | 3.18669082 |
| 83 | positive regulation of neurotransmitter transport (GO:0051590) | 3.18398597 |
| 84 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.17991641 |
| 85 | regulation of synaptic plasticity (GO:0048167) | 3.13706155 |
| 86 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.13039022 |
| 87 | regulation of vesicle fusion (GO:0031338) | 3.12035806 |
| 88 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.11797492 |
| 89 | behavioral defense response (GO:0002209) | 3.11165944 |
| 90 | behavioral fear response (GO:0001662) | 3.11165944 |
| 91 | dendrite morphogenesis (GO:0048813) | 3.07641764 |
| 92 | activation of protein kinase A activity (GO:0034199) | 3.07482425 |
| 93 | long-term memory (GO:0007616) | 3.07405201 |
| 94 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.06859691 |
| 95 | negative regulation of dendrite development (GO:2000171) | 3.06108360 |
| 96 | regulation of glutamate secretion (GO:0014048) | 3.05808673 |
| 97 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.04531116 |
| 98 | dendrite development (GO:0016358) | 3.03943675 |
| 99 | transmission of nerve impulse (GO:0019226) | 3.03479052 |
| 100 | mechanosensory behavior (GO:0007638) | 3.02753439 |
| 101 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.02435595 |
| 102 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.02055295 |
| 103 | regulation of neurotransmitter transport (GO:0051588) | 3.02043571 |
| 104 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.01137863 |
| 105 | establishment of synaptic vesicle localization (GO:0097480) | 2.99308191 |
| 106 | synaptic vesicle transport (GO:0048489) | 2.99308191 |
| 107 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.99012933 |
| 108 | learning (GO:0007612) | 2.98949349 |
| 109 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.98891431 |
| 110 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.98891431 |
| 111 | head development (GO:0060322) | 2.98520188 |
| 112 | regulation of synapse assembly (GO:0051963) | 2.98262797 |
| 113 | glial cell proliferation (GO:0014009) | 2.98154966 |
| 114 | neuronal ion channel clustering (GO:0045161) | 2.97074463 |
| 115 | ferric iron transport (GO:0015682) | 2.96940966 |
| 116 | trivalent inorganic cation transport (GO:0072512) | 2.96940966 |
| 117 | organelle transport along microtubule (GO:0072384) | 2.95977703 |
| 118 | fear response (GO:0042596) | 2.94988643 |
| 119 | membrane depolarization (GO:0051899) | 2.94589424 |
| 120 | response to auditory stimulus (GO:0010996) | 2.93617859 |
| 121 | synaptic transmission (GO:0007268) | 2.93245202 |
| 122 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.93005194 |
| 123 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.92659634 |
| 124 | central nervous system neuron axonogenesis (GO:0021955) | 2.87271661 |
| 125 | synapse organization (GO:0050808) | 2.85974823 |
| 126 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.84613229 |
| 127 | epithelial cell differentiation involved in kidney development (GO:0035850) | 2.84467961 |
| 128 | neuromuscular synaptic transmission (GO:0007274) | 2.82802826 |
| 129 | nonmotile primary cilium assembly (GO:0035058) | 2.80348098 |
| 130 | olfactory bulb development (GO:0021772) | 2.78584339 |
| 131 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.77737691 |
| 132 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.77737691 |
| 133 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 2.76659352 |
| 134 | behavioral response to ethanol (GO:0048149) | 2.75488968 |
| 135 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.75178883 |
| 136 | positive regulation of amino acid transport (GO:0051957) | 2.74208850 |
| 137 | protein polyglutamylation (GO:0018095) | 2.73666350 |
| 138 | short-term memory (GO:0007614) | 2.73537286 |
| 139 | ribonucleoprotein complex disassembly (GO:0032988) | 2.72503771 |
| 140 | cytoskeleton-dependent intracellular transport (GO:0030705) | 2.72145596 |
| 141 | regulation of alternative mRNA splicing, via spliceosome (GO:0000381) | 2.71387771 |
| 142 | DNA damage response, detection of DNA damage (GO:0042769) | 2.68293791 |
| 143 | protein insertion into membrane (GO:0051205) | 2.67779477 |
| 144 | forebrain neuron differentiation (GO:0021879) | 2.67461501 |
| 145 | establishment of vesicle localization (GO:0051650) | 2.67046426 |
| 146 | cardiac ventricle formation (GO:0003211) | 2.64563225 |
| 147 | ganglion development (GO:0061548) | 2.64484914 |
| 148 | protein-cofactor linkage (GO:0018065) | 2.63093259 |
| 149 | spinal cord development (GO:0021510) | 2.60642179 |
| 150 | axonogenesis (GO:0007409) | 2.59723922 |
| 151 | axon extension (GO:0048675) | 2.59091122 |
| 152 | neuronal action potential (GO:0019228) | 2.59005095 |
| 153 | cullin deneddylation (GO:0010388) | 2.58276630 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.99095757 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.25016324 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.09174610 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.95276029 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.85976213 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.79874407 |
| 7 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.78079894 |
| 8 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.61541475 |
| 9 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.56386608 |
| 10 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.51401121 |
| 11 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.48596385 |
| 12 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.48105787 |
| 13 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.46692878 |
| 14 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.46692878 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.42885094 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.40908688 |
| 17 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.34773412 |
| 18 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.31630854 |
| 19 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.29428209 |
| 20 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.25034375 |
| 21 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.19013048 |
| 22 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.12755973 |
| 23 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.11763030 |
| 24 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.11613846 |
| 25 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.09381545 |
| 26 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.08729369 |
| 27 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.07945503 |
| 28 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.03910512 |
| 29 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.02566546 |
| 30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.94357882 |
| 31 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.93904908 |
| 32 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.84769879 |
| 33 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.84408465 |
| 34 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.83530933 |
| 35 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.75808527 |
| 36 | EWS_26573619_Chip-Seq_HEK293_Human | 1.74985300 |
| 37 | P300_19829295_ChIP-Seq_ESCs_Human | 1.74706965 |
| 38 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.72021448 |
| 39 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.70856386 |
| 40 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.65003028 |
| 41 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.63023531 |
| 42 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.61926162 |
| 43 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.61504626 |
| 44 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.59086551 |
| 45 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.58388584 |
| 46 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.57107492 |
| 47 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.55972403 |
| 48 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.51073662 |
| 49 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.44343562 |
| 50 | FUS_26573619_Chip-Seq_HEK293_Human | 1.44304661 |
| 51 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.44301258 |
| 52 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.42697629 |
| 53 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.42053843 |
| 54 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.41964594 |
| 55 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.41005649 |
| 56 | AR_25329375_ChIP-Seq_VCAP_Human | 1.39947468 |
| 57 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.38961232 |
| 58 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.38950277 |
| 59 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.37966311 |
| 60 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.37441890 |
| 61 | VDR_22108803_ChIP-Seq_LS180_Human | 1.37165735 |
| 62 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.31438638 |
| 63 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.31238279 |
| 64 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.30285999 |
| 65 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.24347402 |
| 66 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.22879264 |
| 67 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.21994483 |
| 68 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.21151930 |
| 69 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.18913467 |
| 70 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.18073718 |
| 71 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.17672239 |
| 72 | STAT3_23295773_ChIP-Seq_U87_Human | 1.17540144 |
| 73 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.16542378 |
| 74 | JUN_21703547_ChIP-Seq_K562_Human | 1.16440619 |
| 75 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16379162 |
| 76 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.16003489 |
| 77 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.15996058 |
| 78 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.15075698 |
| 79 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.13494809 |
| 80 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.12156104 |
| 81 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.12069648 |
| 82 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.11466151 |
| 83 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.10685988 |
| 84 | TCF4_23295773_ChIP-Seq_U87_Human | 1.10110114 |
| 85 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.10076759 |
| 86 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.09344167 |
| 87 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.09314248 |
| 88 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.08296327 |
| 89 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.07221036 |
| 90 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.06106183 |
| 91 | AR_19668381_ChIP-Seq_PC3_Human | 1.05518381 |
| 92 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.05517858 |
| 93 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.04749851 |
| 94 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.03907580 |
| 95 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03907580 |
| 96 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.03832784 |
| 97 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.03693518 |
| 98 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.01953636 |
| 99 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.01253543 |
| 100 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00743377 |
| 101 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.99743622 |
| 102 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.98101477 |
| 103 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.97380465 |
| 104 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.97016175 |
| 105 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.96282621 |
| 106 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.95181460 |
| 107 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.95137973 |
| 108 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.95017917 |
| 109 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.94969186 |
| 110 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.94897415 |
| 111 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.93905664 |
| 112 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93730979 |
| 113 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.93253108 |
| 114 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.92946048 |
| 115 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.92724636 |
| 116 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.92081357 |
| 117 | KDM2B_26808549_Chip-Seq_REH_Human | 0.91815607 |
| 118 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.91218236 |
| 119 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.90451895 |
| 120 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.89354104 |
| 121 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.89354104 |
| 122 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.87758972 |
| 123 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.87533534 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.28572670 |
| 2 | MP0003880_abnormal_central_pattern | 4.92406409 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.87829638 |
| 4 | MP0004270_analgesia | 3.67587803 |
| 5 | MP0001968_abnormal_touch/_nociception | 3.27856974 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.27660740 |
| 7 | MP0009745_abnormal_behavioral_response | 3.25710870 |
| 8 | MP0009046_muscle_twitch | 3.01218520 |
| 9 | MP0002064_seizures | 3.00870596 |
| 10 | MP0002734_abnormal_mechanical_nocicepti | 2.87489172 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.84525998 |
| 12 | MP0002735_abnormal_chemical_nociception | 2.84204468 |
| 13 | MP0002736_abnormal_nociception_after | 2.77178332 |
| 14 | MP0005423_abnormal_somatic_nervous | 2.66613162 |
| 15 | MP0006276_abnormal_autonomic_nervous | 2.63861743 |
| 16 | MP0002272_abnormal_nervous_system | 2.40983857 |
| 17 | MP0001440_abnormal_grooming_behavior | 2.31184941 |
| 18 | MP0001486_abnormal_startle_reflex | 2.31133762 |
| 19 | MP0000778_abnormal_nervous_system | 2.30986690 |
| 20 | MP0002733_abnormal_thermal_nociception | 2.28547606 |
| 21 | MP0002184_abnormal_innervation | 2.12071862 |
| 22 | MP0001970_abnormal_pain_threshold | 2.10665439 |
| 23 | MP0002067_abnormal_sensory_capabilities | 2.09067540 |
| 24 | MP0001529_abnormal_vocalization | 2.05207708 |
| 25 | MP0002822_catalepsy | 2.05202267 |
| 26 | MP0001501_abnormal_sleep_pattern | 1.98090338 |
| 27 | MP0003787_abnormal_imprinting | 1.92049428 |
| 28 | MP0003122_maternal_imprinting | 1.91916834 |
| 29 | MP0005386_behavior/neurological_phenoty | 1.87049412 |
| 30 | MP0004924_abnormal_behavior | 1.87049412 |
| 31 | MP0002557_abnormal_social/conspecific_i | 1.85594510 |
| 32 | MP0009780_abnormal_chondrocyte_physiolo | 1.81366223 |
| 33 | MP0004811_abnormal_neuron_physiology | 1.81168967 |
| 34 | MP0001984_abnormal_olfaction | 1.79118580 |
| 35 | MP0005645_abnormal_hypothalamus_physiol | 1.67005081 |
| 36 | MP0005646_abnormal_pituitary_gland | 1.63599947 |
| 37 | MP0004858_abnormal_nervous_system | 1.63083052 |
| 38 | MP0001905_abnormal_dopamine_level | 1.59610150 |
| 39 | MP0003879_abnormal_hair_cell | 1.58199915 |
| 40 | MP0000955_abnormal_spinal_cord | 1.57164523 |
| 41 | MP0001188_hyperpigmentation | 1.55577907 |
| 42 | MP0008569_lethality_at_weaning | 1.49381012 |
| 43 | MP0000049_abnormal_middle_ear | 1.46871675 |
| 44 | MP0004142_abnormal_muscle_tone | 1.46161851 |
| 45 | MP0002882_abnormal_neuron_morphology | 1.45854633 |
| 46 | MP0003329_amyloid_beta_deposits | 1.44869891 |
| 47 | MP0002066_abnormal_motor_capabilities/c | 1.40756239 |
| 48 | MP0003221_abnormal_cardiomyocyte_apopto | 1.37959862 |
| 49 | MP0002909_abnormal_adrenal_gland | 1.34107399 |
| 50 | MP0004133_heterotaxia | 1.33727896 |
| 51 | MP0000751_myopathy | 1.31251078 |
| 52 | MP0002837_dystrophic_cardiac_calcinosis | 1.29525192 |
| 53 | MP0008995_early_reproductive_senescence | 1.23351881 |
| 54 | MP0002234_abnormal_pharynx_morphology | 1.21994438 |
| 55 | MP0003890_abnormal_embryonic-extraembry | 1.19686357 |
| 56 | MP0002152_abnormal_brain_morphology | 1.16398830 |
| 57 | MP0005253_abnormal_eye_physiology | 1.16381175 |
| 58 | MP0001502_abnormal_circadian_rhythm | 1.15982338 |
| 59 | MP0002876_abnormal_thyroid_physiology | 1.11735999 |
| 60 | MP0003119_abnormal_digestive_system | 1.06804534 |
| 61 | MP0005394_taste/olfaction_phenotype | 1.05919591 |
| 62 | MP0005499_abnormal_olfactory_system | 1.05919591 |
| 63 | MP0006072_abnormal_retinal_apoptosis | 1.04155151 |
| 64 | MP0010386_abnormal_urinary_bladder | 1.01910703 |
| 65 | MP0003938_abnormal_ear_development | 1.01124490 |
| 66 | MP0004885_abnormal_endolymph | 1.00813807 |
| 67 | MP0000631_abnormal_neuroendocrine_gland | 0.97515987 |
| 68 | MP0003633_abnormal_nervous_system | 0.96173208 |
| 69 | MP0002069_abnormal_eating/drinking_beha | 0.95597285 |
| 70 | MP0006292_abnormal_olfactory_placode | 0.94858316 |
| 71 | MP0003011_delayed_dark_adaptation | 0.94307940 |
| 72 | MP0004742_abnormal_vestibular_system | 0.93962902 |
| 73 | MP0001963_abnormal_hearing_physiology | 0.90869484 |
| 74 | MP0002233_abnormal_nose_morphology | 0.90180991 |
| 75 | MP0000569_abnormal_digit_pigmentation | 0.89960811 |
| 76 | MP0002752_abnormal_somatic_nervous | 0.89647042 |
| 77 | MP0003631_nervous_system_phenotype | 0.88560054 |
| 78 | MP0002229_neurodegeneration | 0.88292008 |
| 79 | MP0005084_abnormal_gallbladder_morpholo | 0.86777623 |
| 80 | MP0004085_abnormal_heartbeat | 0.84155496 |
| 81 | MP0000647_abnormal_sebaceous_gland | 0.82280958 |
| 82 | MP0003121_genomic_imprinting | 0.81856900 |
| 83 | MP0002751_abnormal_autonomic_nervous | 0.80999937 |
| 84 | MP0008872_abnormal_physiological_respon | 0.80917530 |
| 85 | MP0001485_abnormal_pinna_reflex | 0.80566152 |
| 86 | MP0003646_muscle_fatigue | 0.79432529 |
| 87 | MP0005551_abnormal_eye_electrophysiolog | 0.78622821 |
| 88 | MP0000013_abnormal_adipose_tissue | 0.78440134 |
| 89 | MP0004145_abnormal_muscle_electrophysio | 0.78160895 |
| 90 | MP0002638_abnormal_pupillary_reflex | 0.77800759 |
| 91 | MP0005195_abnormal_posterior_eye | 0.75910088 |
| 92 | MP0003755_abnormal_palate_morphology | 0.75440308 |
| 93 | MP0001986_abnormal_taste_sensitivity | 0.74509209 |
| 94 | MP0000516_abnormal_urinary_system | 0.72080556 |
| 95 | MP0005367_renal/urinary_system_phenotyp | 0.72080556 |
| 96 | MP0001664_abnormal_digestion | 0.71931786 |
| 97 | MP0005535_abnormal_body_temperature | 0.70820604 |
| 98 | MP0003861_abnormal_nervous_system | 0.70541619 |
| 99 | MP0003567_abnormal_fetal_cardiomyocyte | 0.70500014 |
| 100 | MP0004233_abnormal_muscle_weight | 0.70022187 |
| 101 | MP0003385_abnormal_body_wall | 0.69982505 |
| 102 | MP0003634_abnormal_glial_cell | 0.69970627 |
| 103 | MP0002081_perinatal_lethality | 0.67757522 |
| 104 | MP0008874_decreased_physiological_sensi | 0.67627879 |
| 105 | MP0008789_abnormal_olfactory_epithelium | 0.67627685 |
| 106 | MP0002102_abnormal_ear_morphology | 0.67423382 |
| 107 | MP0004484_altered_response_of | 0.66732530 |
| 108 | MP0000026_abnormal_inner_ear | 0.66388926 |
| 109 | MP0004215_abnormal_myocardial_fiber | 0.66112713 |
| 110 | MP0003937_abnormal_limbs/digits/tail_de | 0.65137461 |
| 111 | MP0001943_abnormal_respiration | 0.62662535 |
| 112 | MP0001177_atelectasis | 0.61661746 |
| 113 | MP0008877_abnormal_DNA_methylation | 0.61419980 |
| 114 | MP0003632_abnormal_nervous_system | 0.60036112 |
| 115 | MP0002653_abnormal_ependyma_morphology | 0.59703759 |
| 116 | MP0003183_abnormal_peptide_metabolism | 0.58741785 |
| 117 | MP0003137_abnormal_impulse_conducting | 0.58030459 |
| 118 | MP0006035_abnormal_mitochondrial_morpho | 0.57661738 |
| 119 | MP0002082_postnatal_lethality | 0.57065862 |
| 120 | MP0010770_preweaning_lethality | 0.57065862 |
| 121 | MP0010769_abnormal_survival | 0.54739024 |
| 122 | MP0005187_abnormal_penis_morphology | 0.52943693 |
| 123 | MP0000604_amyloidosis | 0.52341854 |
| 124 | MP0010768_mortality/aging | 0.51724287 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.01408776 |
| 2 | Myokymia (HP:0002411) | 5.61889296 |
| 3 | Epileptic encephalopathy (HP:0200134) | 5.11944930 |
| 4 | Focal seizures (HP:0007359) | 5.10878882 |
| 5 | Atonic seizures (HP:0010819) | 4.95433026 |
| 6 | Visual hallucinations (HP:0002367) | 4.57820400 |
| 7 | Febrile seizures (HP:0002373) | 4.43320823 |
| 8 | Hyperventilation (HP:0002883) | 4.28663050 |
| 9 | Absence seizures (HP:0002121) | 4.00472243 |
| 10 | Progressive cerebellar ataxia (HP:0002073) | 3.94120206 |
| 11 | Cortical dysplasia (HP:0002539) | 3.66615958 |
| 12 | Dialeptic seizures (HP:0011146) | 3.66405447 |
| 13 | Polyphagia (HP:0002591) | 3.66330372 |
| 14 | Broad-based gait (HP:0002136) | 3.59354012 |
| 15 | Limb dystonia (HP:0002451) | 3.46321247 |
| 16 | Retinal dysplasia (HP:0007973) | 3.45008741 |
| 17 | Generalized tonic-clonic seizures (HP:0002069) | 3.44539568 |
| 18 | Abnormal hair whorl (HP:0010721) | 3.25175702 |
| 19 | Amblyopia (HP:0000646) | 3.21269735 |
| 20 | Pheochromocytoma (HP:0002666) | 3.19688779 |
| 21 | Abnormal eating behavior (HP:0100738) | 3.19271239 |
| 22 | Pachygyria (HP:0001302) | 3.08574319 |
| 23 | Progressive inability to walk (HP:0002505) | 3.04530173 |
| 24 | Drooling (HP:0002307) | 3.02933957 |
| 25 | Excessive salivation (HP:0003781) | 3.02933957 |
| 26 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.99552038 |
| 27 | Gait imbalance (HP:0002141) | 2.98133310 |
| 28 | Failure to thrive in infancy (HP:0001531) | 2.95064212 |
| 29 | Mutism (HP:0002300) | 2.92355229 |
| 30 | Neuroendocrine neoplasm (HP:0100634) | 2.92336434 |
| 31 | Ankle clonus (HP:0011448) | 2.91123218 |
| 32 | Epileptiform EEG discharges (HP:0011182) | 2.87024395 |
| 33 | Poor eye contact (HP:0000817) | 2.83837372 |
| 34 | Poor suck (HP:0002033) | 2.80536751 |
| 35 | Supranuclear gaze palsy (HP:0000605) | 2.79144250 |
| 36 | EEG with generalized epileptiform discharges (HP:0011198) | 2.69922509 |
| 37 | Inability to walk (HP:0002540) | 2.67996345 |
| 38 | Truncal ataxia (HP:0002078) | 2.67956633 |
| 39 | Split foot (HP:0001839) | 2.64868321 |
| 40 | Termporal pattern (HP:0011008) | 2.64450361 |
| 41 | Insidious onset (HP:0003587) | 2.64450361 |
| 42 | Genital tract atresia (HP:0001827) | 2.64330721 |
| 43 | Fetal akinesia sequence (HP:0001989) | 2.63123007 |
| 44 | Abnormality of the corticospinal tract (HP:0002492) | 2.62807880 |
| 45 | Gaze-evoked nystagmus (HP:0000640) | 2.62318525 |
| 46 | Spastic tetraplegia (HP:0002510) | 2.61558895 |
| 47 | Amyotrophic lateral sclerosis (HP:0007354) | 2.60922427 |
| 48 | Vaginal atresia (HP:0000148) | 2.59808160 |
| 49 | Hypsarrhythmia (HP:0002521) | 2.58938060 |
| 50 | Abnormal social behavior (HP:0012433) | 2.56931451 |
| 51 | Impaired social interactions (HP:0000735) | 2.56931451 |
| 52 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.53114999 |
| 53 | Anxiety (HP:0000739) | 2.51942356 |
| 54 | Akinesia (HP:0002304) | 2.51768434 |
| 55 | Action tremor (HP:0002345) | 2.51341913 |
| 56 | Urinary urgency (HP:0000012) | 2.48344556 |
| 57 | Depression (HP:0000716) | 2.44953675 |
| 58 | Hypoplasia of the brainstem (HP:0002365) | 2.43833773 |
| 59 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.43833773 |
| 60 | Abnormality of the labia minora (HP:0012880) | 2.41729512 |
| 61 | Dysdiadochokinesis (HP:0002075) | 2.41134378 |
| 62 | Acute necrotizing encephalopathy (HP:0006965) | 2.40386331 |
| 63 | Pancreatic cysts (HP:0001737) | 2.36152321 |
| 64 | Specific learning disability (HP:0001328) | 2.35760390 |
| 65 | Protruding tongue (HP:0010808) | 2.34220685 |
| 66 | Medial flaring of the eyebrow (HP:0010747) | 2.32902322 |
| 67 | Hypothermia (HP:0002045) | 2.31942652 |
| 68 | Abnormality of binocular vision (HP:0011514) | 2.30609662 |
| 69 | Diplopia (HP:0000651) | 2.30609662 |
| 70 | Congenital primary aphakia (HP:0007707) | 2.29747146 |
| 71 | Abnormality of midbrain morphology (HP:0002418) | 2.29298371 |
| 72 | Molar tooth sign on MRI (HP:0002419) | 2.29298371 |
| 73 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.28846625 |
| 74 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.28846625 |
| 75 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.28160691 |
| 76 | Oligomenorrhea (HP:0000876) | 2.25703167 |
| 77 | Spastic gait (HP:0002064) | 2.24462876 |
| 78 | Pancreatic fibrosis (HP:0100732) | 2.24145067 |
| 79 | Sleep apnea (HP:0010535) | 2.23431518 |
| 80 | Progressive macrocephaly (HP:0004481) | 2.22962967 |
| 81 | Nephronophthisis (HP:0000090) | 2.22269649 |
| 82 | True hermaphroditism (HP:0010459) | 2.22059291 |
| 83 | Absent speech (HP:0001344) | 2.21243978 |
| 84 | Hypoventilation (HP:0002791) | 2.21003352 |
| 85 | Genetic anticipation (HP:0003743) | 2.19701792 |
| 86 | Polymicrogyria (HP:0002126) | 2.18762910 |
| 87 | Abnormality of the lower motor neuron (HP:0002366) | 2.18409721 |
| 88 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.17977542 |
| 89 | Esotropia (HP:0000565) | 2.17575234 |
| 90 | Nephrogenic diabetes insipidus (HP:0009806) | 2.16893938 |
| 91 | Pendular nystagmus (HP:0012043) | 2.14761940 |
| 92 | Dysmetria (HP:0001310) | 2.13759425 |
| 93 | Torticollis (HP:0000473) | 2.13416047 |
| 94 | Lissencephaly (HP:0001339) | 2.12457920 |
| 95 | Type II lissencephaly (HP:0007260) | 2.11104464 |
| 96 | Hepatoblastoma (HP:0002884) | 2.08937128 |
| 97 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.07890218 |
| 98 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.07890218 |
| 99 | Focal dystonia (HP:0004373) | 2.07775228 |
| 100 | Poor coordination (HP:0002370) | 2.06616205 |
| 101 | Muscular hypotonia of the trunk (HP:0008936) | 2.05814472 |
| 102 | Shoulder girdle muscle weakness (HP:0003547) | 2.05781045 |
| 103 | Cerebral inclusion bodies (HP:0100314) | 2.05513079 |
| 104 | Agitation (HP:0000713) | 2.05498819 |
| 105 | Hyperthyroidism (HP:0000836) | 2.05419300 |
| 106 | Exotropia (HP:0000577) | 2.04316709 |
| 107 | Intestinal atresia (HP:0011100) | 2.03736127 |
| 108 | Bradykinesia (HP:0002067) | 2.02843507 |
| 109 | Thyroid-stimulating hormone excess (HP:0002925) | 2.02708856 |
| 110 | Narrow nasal bridge (HP:0000446) | 2.00116891 |
| 111 | Abnormality of salivation (HP:0100755) | 1.97533634 |
| 112 | Lower limb muscle weakness (HP:0007340) | 1.96866796 |
| 113 | Hemiparesis (HP:0001269) | 1.96677270 |
| 114 | Generalized hypotonia (HP:0001290) | 1.96002481 |
| 115 | Stereotypic behavior (HP:0000733) | 1.95518974 |
| 116 | Hypoplasia of the corpus callosum (HP:0002079) | 1.95262662 |
| 117 | Delusions (HP:0000746) | 1.94599579 |
| 118 | Blue irides (HP:0000635) | 1.93559046 |
| 119 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.92948389 |
| 120 | Scanning speech (HP:0002168) | 1.92601068 |
| 121 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.92196692 |
| 122 | Increased serum pyruvate (HP:0003542) | 1.91580329 |
| 123 | Abnormality of glycolysis (HP:0004366) | 1.91580329 |
| 124 | Peripheral hypomyelination (HP:0007182) | 1.91438899 |
| 125 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.89830694 |
| 126 | Abnormality of pain sensation (HP:0010832) | 1.89313630 |
| 127 | Impaired pain sensation (HP:0007328) | 1.89313630 |
| 128 | Patellar aplasia (HP:0006443) | 1.89221624 |
| 129 | Papilledema (HP:0001085) | 1.88622411 |
| 130 | Ulnar claw (HP:0001178) | 1.88308823 |
| 131 | Impaired vibratory sensation (HP:0002495) | 1.88237228 |
| 132 | Impaired smooth pursuit (HP:0007772) | 1.88187055 |
| 133 | Craniofacial dystonia (HP:0012179) | 1.87796100 |
| 134 | Generalized myoclonic seizures (HP:0002123) | 1.86866336 |
| 135 | Narrow forehead (HP:0000341) | 1.85412011 |
| 136 | Postaxial hand polydactyly (HP:0001162) | 1.84684890 |
| 137 | Decreased testicular size (HP:0008734) | 1.84360660 |
| 138 | Methylmalonic acidemia (HP:0002912) | 1.83377498 |
| 139 | Renal cortical cysts (HP:0000803) | 1.82212061 |
| 140 | Rimmed vacuoles (HP:0003805) | 1.80874472 |
| 141 | Optic nerve hypoplasia (HP:0000609) | 1.78614218 |
| 142 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.76943776 |
| 143 | Micropenis (HP:0000054) | 1.76929837 |
| 144 | Chronic hepatic failure (HP:0100626) | 1.76401922 |
| 145 | Abnormality of the renal medulla (HP:0100957) | 1.76036311 |
| 146 | Scrotal hypoplasia (HP:0000046) | 1.74426401 |
| 147 | Labial hypoplasia (HP:0000066) | 1.74236053 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 4.67221965 |
| 2 | CASK | 4.53358516 |
| 3 | NTRK3 | 3.50614486 |
| 4 | MAP3K12 | 3.41732116 |
| 5 | MAP3K4 | 3.27236861 |
| 6 | MAP2K7 | 3.16319020 |
| 7 | TRIM28 | 3.10502694 |
| 8 | MAP3K9 | 2.94204116 |
| 9 | MAP4K2 | 2.75838116 |
| 10 | EPHA4 | 2.73004522 |
| 11 | MINK1 | 2.72829671 |
| 12 | DAPK2 | 2.15118785 |
| 13 | NTRK2 | 2.07701293 |
| 14 | CDK19 | 2.07195709 |
| 15 | PLK2 | 2.05491086 |
| 16 | MAPK13 | 2.04146241 |
| 17 | MAP2K4 | 2.02839598 |
| 18 | DAPK1 | 1.79068289 |
| 19 | PINK1 | 1.74412852 |
| 20 | CSNK1G1 | 1.67203708 |
| 21 | KSR1 | 1.66629336 |
| 22 | GRK5 | 1.60014412 |
| 23 | DYRK3 | 1.58485942 |
| 24 | SIK3 | 1.52963154 |
| 25 | PAK6 | 1.50565230 |
| 26 | EPHA3 | 1.45109531 |
| 27 | PRPF4B | 1.43304060 |
| 28 | SRPK1 | 1.42460629 |
| 29 | PNCK | 1.34564183 |
| 30 | CDK5 | 1.34063887 |
| 31 | PHKG1 | 1.33671564 |
| 32 | PHKG2 | 1.33671564 |
| 33 | DYRK2 | 1.30147350 |
| 34 | TNIK | 1.27297902 |
| 35 | CCNB1 | 1.25134575 |
| 36 | NME1 | 1.23722716 |
| 37 | PRKCG | 1.20790488 |
| 38 | SIK2 | 1.17464885 |
| 39 | ARAF | 1.13855180 |
| 40 | AKT3 | 1.11444986 |
| 41 | UHMK1 | 1.10385875 |
| 42 | OXSR1 | 1.08212829 |
| 43 | KSR2 | 1.07327135 |
| 44 | BCR | 1.05180213 |
| 45 | RPS6KA4 | 1.04281450 |
| 46 | DYRK1B | 1.04227975 |
| 47 | FRK | 1.04152704 |
| 48 | LATS2 | 1.00683736 |
| 49 | CDK18 | 0.99740315 |
| 50 | CAMK2A | 0.98983682 |
| 51 | NTRK1 | 0.98660190 |
| 52 | CAMKK1 | 0.96770686 |
| 53 | CDK14 | 0.95413104 |
| 54 | RIPK4 | 0.94957495 |
| 55 | ERBB3 | 0.94820950 |
| 56 | LIMK1 | 0.93780739 |
| 57 | CSNK1G2 | 0.91803719 |
| 58 | CDK15 | 0.90248444 |
| 59 | SGK494 | 0.87030284 |
| 60 | SGK223 | 0.87030284 |
| 61 | CAMKK2 | 0.85354889 |
| 62 | DYRK1A | 0.84004098 |
| 63 | PDK3 | 0.83726108 |
| 64 | PDK4 | 0.83726108 |
| 65 | BCKDK | 0.82012095 |
| 66 | SGK2 | 0.80112488 |
| 67 | CAMK2B | 0.79858865 |
| 68 | TSSK6 | 0.79102588 |
| 69 | CDK11A | 0.78017626 |
| 70 | WNK3 | 0.76718262 |
| 71 | GRK1 | 0.70109637 |
| 72 | TESK1 | 0.67478632 |
| 73 | FES | 0.66748017 |
| 74 | PRKCE | 0.66070951 |
| 75 | PAK3 | 0.63763970 |
| 76 | PTK2B | 0.63505548 |
| 77 | MAP3K5 | 0.63140843 |
| 78 | GRK7 | 0.62947296 |
| 79 | MAP3K6 | 0.59649443 |
| 80 | INSRR | 0.58819927 |
| 81 | RPS6KA2 | 0.58465722 |
| 82 | BRAF | 0.56452081 |
| 83 | STK11 | 0.55586899 |
| 84 | ADRBK1 | 0.55267800 |
| 85 | TYRO3 | 0.54640677 |
| 86 | CSNK1G3 | 0.53972784 |
| 87 | BMPR1B | 0.52325955 |
| 88 | PRKD3 | 0.50689178 |
| 89 | BMPR2 | 0.50622084 |
| 90 | PRKCZ | 0.50479600 |
| 91 | MARK2 | 0.50278303 |
| 92 | RET | 0.50100853 |
| 93 | MAP3K2 | 0.48366449 |
| 94 | FGR | 0.47477569 |
| 95 | SGK1 | 0.47114045 |
| 96 | ADRBK2 | 0.45249762 |
| 97 | MAPK12 | 0.44525122 |
| 98 | PRKACA | 0.44398133 |
| 99 | CSNK1D | 0.44130968 |
| 100 | EPHB2 | 0.44054773 |
| 101 | CSNK1A1 | 0.42985146 |
| 102 | SGK3 | 0.42429196 |
| 103 | DAPK3 | 0.42321755 |
| 104 | CAMK1 | 0.41834920 |
| 105 | TESK2 | 0.40813228 |
| 106 | RAF1 | 0.39956686 |
| 107 | MAP2K1 | 0.39933249 |
| 108 | CSNK1E | 0.39333501 |
| 109 | PKN1 | 0.39023747 |
| 110 | TAOK1 | 0.39016554 |
| 111 | RPS6KA5 | 0.38903323 |
| 112 | STK38 | 0.38376128 |
| 113 | FER | 0.38062923 |
| 114 | PRKACB | 0.37730802 |
| 115 | STK38L | 0.37472800 |
| 116 | PRKAA1 | 0.37414522 |
| 117 | NEK1 | 0.37288867 |
| 118 | CAMK2D | 0.36021053 |
| 119 | CAMK2G | 0.35837728 |
| 120 | PRKG1 | 0.34768592 |
| 121 | MAPK9 | 0.34373432 |
| 122 | PRKCH | 0.32773408 |
| 123 | ROCK2 | 0.30353050 |
| 124 | MYLK | 0.30011721 |
| 125 | CAMK4 | 0.29882387 |
| 126 | FYN | 0.29433214 |
| 127 | RPS6KA3 | 0.29273844 |
| 128 | CSNK1A1L | 0.29208531 |
| 129 | VRK1 | 0.25864650 |
| 130 | PRKACG | 0.23870184 |
| 131 | WNK4 | 0.23863863 |
| 132 | MAPK4 | 0.22867974 |
| 133 | PRKCB | 0.22438701 |
| 134 | CDK3 | 0.22220512 |
| 135 | MAPK8 | 0.21887365 |
| 136 | ZAK | 0.21141941 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.02770748 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.98834787 |
| 3 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.81165961 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.74179479 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.63522678 |
| 6 | Olfactory transduction_Homo sapiens_hsa04740 | 2.49227309 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.47631076 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.44007082 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.38329497 |
| 10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.29859220 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.26475886 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.23415393 |
| 13 | Protein export_Homo sapiens_hsa03060 | 1.98757788 |
| 14 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.92967319 |
| 15 | Taste transduction_Homo sapiens_hsa04742 | 1.90865514 |
| 16 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.88383824 |
| 17 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.82901373 |
| 18 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.82715746 |
| 19 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.80071788 |
| 20 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.79856592 |
| 21 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.76515117 |
| 22 | Salivary secretion_Homo sapiens_hsa04970 | 1.75487302 |
| 23 | Insulin secretion_Homo sapiens_hsa04911 | 1.74419624 |
| 24 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.71845643 |
| 25 | Long-term depression_Homo sapiens_hsa04730 | 1.65922287 |
| 26 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.65411025 |
| 27 | Renin secretion_Homo sapiens_hsa04924 | 1.61341131 |
| 28 | Cocaine addiction_Homo sapiens_hsa05030 | 1.57100529 |
| 29 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.49882715 |
| 30 | Parkinsons disease_Homo sapiens_hsa05012 | 1.49386616 |
| 31 | Axon guidance_Homo sapiens_hsa04360 | 1.44302300 |
| 32 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.42778021 |
| 33 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.41696659 |
| 34 | Alzheimers disease_Homo sapiens_hsa05010 | 1.41092724 |
| 35 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.40143131 |
| 36 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.38547127 |
| 37 | Basal transcription factors_Homo sapiens_hsa03022 | 1.38152946 |
| 38 | Gap junction_Homo sapiens_hsa04540 | 1.36767222 |
| 39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.36063650 |
| 40 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.35978973 |
| 41 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.30099974 |
| 42 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.26718270 |
| 43 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.25185752 |
| 44 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.21501472 |
| 45 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.19647650 |
| 46 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.16653311 |
| 47 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.14442993 |
| 48 | Huntingtons disease_Homo sapiens_hsa05016 | 1.05009415 |
| 49 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.03317499 |
| 50 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.02463094 |
| 51 | Phototransduction_Homo sapiens_hsa04744 | 1.02202841 |
| 52 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.01978339 |
| 53 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.98092699 |
| 54 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.94823627 |
| 55 | Glioma_Homo sapiens_hsa05214 | 0.88509044 |
| 56 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.87127213 |
| 57 | Melanogenesis_Homo sapiens_hsa04916 | 0.86881067 |
| 58 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.85009861 |
| 59 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.82967746 |
| 60 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.82586376 |
| 61 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.81158297 |
| 62 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.79104112 |
| 63 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.77911440 |
| 64 | Phagosome_Homo sapiens_hsa04145 | 0.73821168 |
| 65 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.73619877 |
| 66 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.71985702 |
| 67 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.71235504 |
| 68 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.68290563 |
| 69 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.65027756 |
| 70 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.64164551 |
| 71 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.60549732 |
| 72 | Alcoholism_Homo sapiens_hsa05034 | 0.59943898 |
| 73 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.59247428 |
| 74 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.59209521 |
| 75 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.58634948 |
| 76 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.58155807 |
| 77 | Peroxisome_Homo sapiens_hsa04146 | 0.57449080 |
| 78 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.56218873 |
| 79 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.54961132 |
| 80 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.53780934 |
| 81 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.53497455 |
| 82 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.53142362 |
| 83 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.52134026 |
| 84 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.52021417 |
| 85 | Endometrial cancer_Homo sapiens_hsa05213 | 0.51755307 |
| 86 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.51747095 |
| 87 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.51588550 |
| 88 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.50729921 |
| 89 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.50525397 |
| 90 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.50146030 |
| 91 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.49771248 |
| 92 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.49124005 |
| 93 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.48800318 |
| 94 | RNA degradation_Homo sapiens_hsa03018 | 0.48751458 |
| 95 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.48167365 |
| 96 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.47743541 |
| 97 | Colorectal cancer_Homo sapiens_hsa05210 | 0.46896551 |
| 98 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.46392547 |
| 99 | RNA polymerase_Homo sapiens_hsa03020 | 0.45427255 |
| 100 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.44546486 |
| 101 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.43868535 |
| 102 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.42346336 |
| 103 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.42313551 |
| 104 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.41956618 |
| 105 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.41938473 |
| 106 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.40640905 |
| 107 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.39923601 |
| 108 | Salmonella infection_Homo sapiens_hsa05132 | 0.39635706 |
| 109 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.38661126 |
| 110 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.38454086 |
| 111 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.38020774 |
| 112 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.37101901 |
| 113 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.37015637 |
| 114 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.36945617 |
| 115 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.36713121 |
| 116 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.36433318 |
| 117 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.36247697 |
| 118 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.35441090 |
| 119 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.35389411 |
| 120 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.34935136 |
| 121 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.34372350 |
| 122 | Endocytosis_Homo sapiens_hsa04144 | 0.33470940 |
| 123 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.32765894 |
| 124 | Metabolic pathways_Homo sapiens_hsa01100 | 0.32603975 |
| 125 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.30988770 |
| 126 | Circadian rhythm_Homo sapiens_hsa04710 | 0.30776765 |
| 127 | Melanoma_Homo sapiens_hsa05218 | 0.30516195 |
| 128 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.29965398 |
| 129 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.29509249 |
| 130 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.28709744 |
| 131 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.28236238 |
| 132 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.27510207 |
| 133 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.26737176 |
| 134 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.25492510 |
| 135 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.23380803 |
| 136 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.21512766 |
| 137 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.17657626 |

